Robert P. Ragusa net worth and biography

Robert Ragusa Biography and Net Worth

SVP of Illumina
Currently, Robert P. Ragusa occupies the position of Chief Operations Officer for Illumina, Inc. and Chief Executive Officer of GRAIL, Inc. (a subsidiary of Illumina, Inc.). Mr. Ragusa is also on the board of Twist Bioscience Corp. and Dante Labs, Inc.

He previously occupied the position of Executive VP-Engineering & Global Operations at Accuray, Inc., Senior Vice President-Global Operations at Applied Biosystems, Inc. and Vice President of Applera Corp.

Robert P. Ragusa received a graduate degree from Carnegie Mellon University and an undergraduate degree and an MBA from the University of Connecticut.

What is Robert P. Ragusa's net worth?

The estimated net worth of Robert P. Ragusa is at least $3.25 million as of June 15th, 2020. Mr. Ragusa owns 17,020 shares of Illumina stock worth more than $3,247,246 as of September 30th. This net worth estimate does not reflect any other investments that Mr. Ragusa may own. Learn More about Robert P. Ragusa's net worth.

How do I contact Robert P. Ragusa?

The corporate mailing address for Mr. Ragusa and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Robert P. Ragusa's contact information.

Has Robert P. Ragusa been buying or selling shares of Illumina?

Robert P. Ragusa has not been actively trading shares of Illumina within the last three months. Most recently, Robert P. Ragusa sold 5,000 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $340.76, for a transaction totalling $1,703,800.00. Following the completion of the sale, the senior vice president now directly owns 17,020 shares of the company's stock, valued at $5,799,735.20. Learn More on Robert P. Ragusa's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 19 times. They sold a total of 21,102 shares worth more than $8,202,908.23. The most recent insider tranaction occured on July, 7th when SVP Alexander Aravanis sold 539 shares worth more than $107,800.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 7/7/2022.

Robert P. Ragusa Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2020Sell5,000$340.76$1,703,800.0017,020View SEC Filing Icon  
8/8/2019Sell2,230$293.09$653,590.7010,685View SEC Filing Icon  
See Full Table

Robert P. Ragusa Buying and Selling Activity at Illumina

This chart shows Robert P Ragusa's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $190.79
Low: $183.65
High: $194.22

50 Day Range

MA: $206.33
Low: $184.12
High: $227.44

2 Week Range

Now: $190.79
Low: $173.45
High: $428.00


2,775,675 shs

Average Volume

1,292,445 shs

Market Capitalization

$29.97 billion

P/E Ratio


Dividend Yield